Efaproxiral Sodium (RSR13 sodium) is a synthetic small molecule allosteric effector of hemoglobin. It has been investigated in preclinical and clinical research for its potential to sensitize hypoxic tumors, such as breast cancer-derived brain metastases, to radiation therapy.